Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination therapy consisting of four medications: **Prednisolone**: A synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties. **Triamcinolone acetonide**: A synthetic corticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. **Mycophenolate mofetil**: An immunosuppressant that inhibits inosine monophosphate dehydrogenase, preventing T and B lymphocyte proliferation. **Dapsone**: A sulfone antibiotic with anti-inflammatory properties. It works by inhibiting bacterial dihydropteroate synthase and has immunomodulatory effects by blocking certain immune cells from causing damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on prednisolone + triamcinolone acetonide + mycophenolate mofetil + dapsone.